高级检索
    钟文昭, 吴一龙. 表皮生长因子受体酪氨酸激酶抑制剂在非小细胞肺癌应用的瓶颈——获得性耐药[J]. 循证医学, 2008, 8(4): 193-197. DOI: 10.3969/j.issn.1671-5144.2008.04.001
    引用本文: 钟文昭, 吴一龙. 表皮生长因子受体酪氨酸激酶抑制剂在非小细胞肺癌应用的瓶颈——获得性耐药[J]. 循证医学, 2008, 8(4): 193-197. DOI: 10.3969/j.issn.1671-5144.2008.04.001
    shu
    ZHONG Wen-zhao, WU Yi-long. The Bottleneck of EGFR-TKI Application in Non-Small Cell Lung Cancer——Acquired Resistance[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 193-197. DOI: 10.3969/j.issn.1671-5144.2008.04.001
    Citation: ZHONG Wen-zhao, WU Yi-long. The Bottleneck of EGFR-TKI Application in Non-Small Cell Lung Cancer——Acquired Resistance[J]. Journal of Evidence-Based Medicine, 2008, 8(4): 193-197. DOI: 10.3969/j.issn.1671-5144.2008.04.001
    shu

    表皮生长因子受体酪氨酸激酶抑制剂在非小细胞肺癌应用的瓶颈——获得性耐药

    The Bottleneck of EGFR-TKI Application in Non-Small Cell Lung Cancer——Acquired Resistance

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回